{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:08:54Z","timestamp":1785766134036,"version":"3.56.0"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/fpc.0000000000000293","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T17:04:46Z","timestamp":1497719086000},"page":"294-302","source":"Crossref","is-referenced-by-count":19,"title":["Genetics of pleiotropic effects of dexamethasone"],"prefix":"10.1097","volume":"27","author":[{"given":"Laura B.","family":"Ramsey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Pounds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colton","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth E.","family":"Karol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Panetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Rubnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika L.","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul C.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Sandlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Jeha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary V.","family":"Relling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210213","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1200\/JCO.1996.14.3.911","article-title":"High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group","volume":"14","author":"Veerman","year":"1996","journal-title":"J Clin Oncol"},{"key":"R2-3-20210213","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1182\/blood.V97.5.1211","article-title":"Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01","volume":"97","author":"Silverman","year":"2001","journal-title":"Blood"},{"key":"R3-3-20210213","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"R4-3-20210213","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","article-title":"Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study \u2013 Dana-Farber Cancer Institute ALL Consortium Protocol 00-01","volume":"31","author":"Vrooman","year":"2013","journal-title":"J Clin Oncol"},{"key":"R5-3-20210213","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2141.2005.05509.x","article-title":"Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial","volume":"129","author":"Mitchell","year":"2005","journal-title":"Br J Haematol"},{"key":"R6-3-20210213","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1182\/blood-2002-08-2454","article-title":"Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children\u2019s Cancer Group","volume":"101","author":"Bostrom","year":"2003","journal-title":"Blood"},{"key":"R7-3-20210213","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00043426-200005000-00004","article-title":"Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone","volume":"22","author":"Waber","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-3-20210213","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","article-title":"Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia","volume":"117","author":"Kawedia","year":"2011","journal-title":"Blood"},{"key":"R9-3-20210213","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-0033-1358723","article-title":"Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis","volume":"226","author":"Kuhlen","year":"2014","journal-title":"Klin Padiatr"},{"key":"R10-3-20210213","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2011.37.3217","article-title":"Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia","volume":"29","author":"te Winkel","year":"2011","journal-title":"J Clin Oncol"},{"key":"R11-3-20210213","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MPH.0000000000000039","article-title":"Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group","volume":"36","author":"Hyakuna","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"R12-3-20210213","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1002\/cncr.28930","article-title":"Augmented Berlin-Frankfurt-Munster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL)","volume":"120","author":"Rytting","year":"2014","journal-title":"Cancer"},{"key":"R13-3-20210213","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.leu.2405032","article-title":"High incidence of avascular necrosis in adolescents with acute lymphoblastic leukaemia: a UKALL XII analysis","volume":"22","author":"Patel","year":"2008","journal-title":"Leukemia"},{"key":"R14-3-20210213","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","article-title":"Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children\u2019s Cancer Group","volume":"18","author":"Mattano","year":"2000","journal-title":"J Clin Oncol"},{"key":"R15-3-20210213","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00004728-200209000-00030","article-title":"MR patterns of involvement of humeral head osteonecrosis","volume":"26","author":"Lee","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"R16-3-20210213","first-page":"747","article-title":"Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia","volume":"88","author":"Arico","year":"2003","journal-title":"Haematologica"},{"key":"R17-3-20210213","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1038\/leu.2012.102","article-title":"Clinical utility and implications of asparaginase antibodies in acute lymphoblastic leukemia","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"key":"R18-3-20210213","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.2011.08871.x","article-title":"Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia","volume":"155","author":"Vora","year":"2011","journal-title":"Br J Haematol"},{"key":"R19-3-20210213","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1182\/blood-2007-11-123885","article-title":"A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"111","author":"French","year":"2008","journal-title":"Blood"},{"key":"R20-3-20210213","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","article-title":"Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia","volume":"22","author":"Relling","year":"2004","journal-title":"J Clin Oncol"},{"key":"R21-3-20210213","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2015-05-643601","article-title":"Genetics of glucocorticoid-associated osteonecrosis in children with acute lymphoblastic leukemia","volume":"126","author":"Karol","year":"2015","journal-title":"Blood"},{"key":"R22-3-20210213","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1504\/IJDMB.2011.039174","article-title":"Integrated analysis of pharmacologic, clinical and SNP microarray data using projection onto the most interesting statistical evidence with adaptive permutation testing","volume":"5","author":"Pounds","year":"2011","journal-title":"Int J Data Min Bioinform"},{"key":"R23-3-20210213","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/bioinformatics\/btp357","article-title":"PROMISE: A tool to identify genomic features with a specific biologically interesting pattern of correlations with multiple endpoint variables","volume":"25","author":"Pounds","year":"2009","journal-title":"Bioinformatics"},{"key":"R24-3-20210213","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12859-016-1217-0","article-title":"CC-PROMISE effectively integrates two forms of molecular data with multiple biologically related endpoints","volume":"17","author":"Cao","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"R25-3-20210213","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1470-2045(12)70274-7","article-title":"Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial","volume":"13","author":"Mattano","year":"2012","journal-title":"Lancet Oncol"},{"key":"R26-3-20210213","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2015-10-673848","article-title":"Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemia","volume":"127","author":"Karol","year":"2016","journal-title":"Blood"},{"key":"R27-3-20210213","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3324\/haematol.2013.095562","article-title":"Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia","volume":"99","author":"Te Winkel","year":"2014","journal-title":"Haematologica"},{"key":"R28-3-20210213","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11912-015-0444-2","article-title":"Thrombosis in leukemia: incidence, causes, and practical management","volume":"17","author":"Guzman-Uribe","year":"2015","journal-title":"Curr Oncol Rep"},{"key":"R29-3-20210213","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N Engl J Med"},{"key":"R30-3-20210213","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2011-09-381731","article-title":"Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia","volume":"119","author":"Kawedia","year":"2012","journal-title":"Blood"},{"key":"R31-3-20210213","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1007\/s00520-015-2718-5","article-title":"The association between glucocorticoid therapy and BMI z-score changes in children with acute lymphoblastic leukemia","volume":"23","author":"Arpe","year":"2015","journal-title":"Support Care Cancer"},{"key":"R32-3-20210213","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/pbc.22237","article-title":"Weight patterns in children with higher risk ALL: a report from the Children\u2019s Oncology Group (COG) for CCG 1961","volume":"53","author":"Withycombe","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"R33-3-20210213","doi-asserted-by":"crossref","first-page":"e26344","DOI":"10.1002\/pbc.26344","article-title":"Changes in body mass index in long-term survivors of childhood acute lymphoblastic leukemia treated without cranial radiation and with reduced glucocorticoid therapy","volume":"64","author":"Touyz","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R34-3-20210213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0268-960X(02)00042-5","article-title":"Endocrine complications in pediatric patients with acute lymphoblastic leukemia","volume":"16","author":"Howard","year":"2002","journal-title":"Blood Rev"},{"key":"R35-3-20210213","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.1200\/JCO.2008.20.4156","article-title":"Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects","volume":"27","author":"Trevino","year":"2009","journal-title":"J Clin Oncol"},{"key":"R36-3-20210213","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2202\/1544-6115.1064","article-title":"Statistical significance threshold criteria for analysis of microarray gene expression data","volume":"3","author":"Cheng","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"R37-3-20210213","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1101\/gr.137323.112","article-title":"Annotation of functional variation in personal genomes using RegulomeDB","volume":"22","author":"Boyle","year":"2012","journal-title":"Genome Res"},{"key":"R38-3-20210213","doi-asserted-by":"crossref","first-page":"e1001279","DOI":"10.1371\/journal.pgen.1001279","article-title":"Global analysis of the impact of environmental perturbation on cis-regulation of gene expression","volume":"7","author":"Grundberg","year":"2011","journal-title":"PLoS Genet"},{"key":"R39-3-20210213","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1161\/CIRCGENETICS.109.877811","article-title":"Genetic variation at the proprotein convertase subtilisin\/kexin type 5 gene modulates high-density lipoprotein cholesterol levels","volume":"2","author":"Iatan","year":"2009","journal-title":"Circ Cardiovasc Genet"},{"key":"R40-3-20210213","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.2337\/db14-0732","article-title":"Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium","volume":"64","author":"Palmer","year":"2015","journal-title":"Diabetes"},{"key":"R41-3-20210213","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng.3097","article-title":"Defining the role of common variation in the genomic and biological architecture of adult human height","volume":"46","author":"Wood","year":"2014","journal-title":"Nat Genet"},{"key":"R42-3-20210213","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ng.2606","article-title":"Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"R43-3-20210213","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature09410","article-title":"Hundreds of variants clustered in genomic loci and biological pathways affect human height","volume":"467","author":"Lango Allen","year":"2010","journal-title":"Nature"},{"key":"R44-3-20210213","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1074\/jbc.M110.178251","article-title":"Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment","volume":"286","author":"Quach","year":"2011","journal-title":"J Biol Chem"},{"key":"R45-3-20210213","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnana.2015.00072","article-title":"Interaction between SCO-spondin and low density lipoproteins from embryonic cerebrospinal fluid modulates their roles in early neurogenesis","volume":"9","author":"Vera","year":"2015","journal-title":"Front Neuroanat"},{"key":"R46-3-20210213","doi-asserted-by":"crossref","first-page":"e87518","DOI":"10.1371\/journal.pone.0087518","article-title":"Mouse model reveals the role of RERE in cerebellar foliation and the migration and maturation of Purkinje cells","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"R47-3-20210213","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajhg.2011.10.004","article-title":"Abundant pleiotropy in human complex diseases and traits","volume":"89","author":"Sivakumaran","year":"2011","journal-title":"Am J Hum Genet"},{"key":"R48-3-20210213","doi-asserted-by":"crossref","first-page":"e0150975","DOI":"10.1371\/journal.pone.0150975","article-title":"Joint analysis of multiple traits using \u2018optimal\u2019 maximum heritability test","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"R49-3-20210213","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nmeth.2848","article-title":"Efficient multivariate linear mixed model algorithms for genome-wide association studies","volume":"11","author":"Zhou","year":"2014","journal-title":"Nat Methods"},{"key":"R50-3-20210213","doi-asserted-by":"crossref","first-page":"e1003235","DOI":"10.1371\/journal.pgen.1003235","article-title":"TATES: efficient multivariate genotype-phenotype analysis for genome-wide association studies","volume":"9","author":"Van der Sluis","year":"2013","journal-title":"PLoS Genet"},{"key":"R51-3-20210213","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/gepi.21931","article-title":"An adaptive association test for multiple phenotypes with gwas summary statistics","volume":"39","author":"Kim","year":"2015","journal-title":"Genet Epidemiol"},{"key":"R52-3-20210213","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/ng.2376","article-title":"A mixed-model approach for genome-wide association studies of correlated traits in structured populations","volume":"44","author":"Korte","year":"2012","journal-title":"Nat Genet"},{"key":"R53-3-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00003086-200105000-00004","article-title":"Hypofibrinolysis, thrombophilia, osteonecrosis","volume":"386","author":"Glueck","year":"2001","journal-title":"Clin Orthop"},{"key":"R54-3-20210213","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/rheumatology\/40.2.196","article-title":"A high low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a potential risk factor for corticosteroid-induced osteonecrosis in rabbits","volume":"40","author":"Miyanishi","year":"2001","journal-title":"Rheumatology(Oxford"},{"key":"R55-3-20210213","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/art.1780401119","article-title":"Effects of pulse methylprednisolone on bone and marrow tissues: corticosteroid-induced osteonecrosis in rabbits","volume":"40","author":"Yamamoto","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R56-3-20210213","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajpath.2013.03.004","article-title":"Primary epiphyseal arteriopathy in a mouse model of steroid-induced osteonecrosis","volume":"183","author":"Janke","year":"2013","journal-title":"Am J Pathol"},{"key":"R57-3-20210213","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.02.007","article-title":"Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action","volume":"114","author":"Kerachian","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R58-3-20210213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.112.2907.295","article-title":"The influence of ACTH and cortisone on certain factors of blood coagulation","volume":"112","author":"Smith","year":"1950","journal-title":"Science"},{"key":"R59-3-20210213","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00003086-199507000-00033","article-title":"Corticosteroid enhances the experimental induction of osteonecrosis in rabbits with Shwartzman reaction","volume":"316","author":"Yamamoto","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"R60-3-20210213","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.2200","article-title":"METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-kappaB signaling pathway","volume":"29","author":"Huang","year":"2014","journal-title":"J Bone Miner Res"},{"key":"R61-3-20210213","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/ng.3561","article-title":"Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease","volume":"48","author":"Helgadottir","year":"2016","journal-title":"Nat Genet"},{"key":"R62-3-20210213","doi-asserted-by":"crossref","first-page":"e14808","DOI":"10.1371\/journal.pone.0014808","article-title":"Using functional annotation for the empirical determination of Bayes Factors for genome-wide association study analysis","volume":"6","author":"Knight","year":"2011","journal-title":"PLoS One"},{"key":"R63-3-20210213","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2164-14-108","article-title":"The genomic signature of trait-associated variants","volume":"14","author":"Kindt","year":"2013","journal-title":"BMC Genomics"},{"key":"R64-3-20210213","doi-asserted-by":"crossref","first-page":"e1000888","DOI":"10.1371\/journal.pgen.1000888","article-title":"Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS","volume":"6","author":"Nicolae","year":"2010","journal-title":"PLoS Genet"},{"key":"R65-3-20210213","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.bone.2011.11.023","article-title":"Proteinase-activated receptor-2 is required for normal osteoblast and osteoclast differentiation during skeletal growth and repair","volume":"50","author":"Georgy","year":"2012","journal-title":"Bone"},{"key":"R66-3-20210213","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature10659","article-title":"New gene functions in megakaryopoiesis and platelet formation","volume":"480","author":"Gieger","year":"2011","journal-title":"Nature"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FPC.0000000000000293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:23:57Z","timestamp":1620951837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-201708000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0000000000000293","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}